Caffeine shows no lasting benefit for preemies with apnea

01/17/2012 | PhysiciansBriefing.com

A five-year study in the Journal of the American Medical Association found that neonatal caffeine treatment for apnea of prematurity did not improve survival without disability. The caffeine group and the placebo group did not differ in terms of mortality rate, behavior problems, motor impairment, poor general health, blindness or deafness, researchers reported.

View Full Article in:

PhysiciansBriefing.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT